Moreover, a low ARHGAP30 level is associated with the activation of Wnt/β-catenin signaling pathways and further leads to lung cancer cell proliferation, migration, and invasion (Mao and Tong, 2018). This evidence concerns the gene ARHGAP30 and lung carcinoma.